tecovirimat
Sign in to saveTecovirimat, sold under the brand name Tpoxx among others, is an antiviral medication with activity against orthopoxviruses such as smallpox and mpox. In 2018 it was the first antipoxviral drug approved in the United States.
Article
9 sectionsContents
- Medical uses
- Mechanism of action
- Chemistry
- History
- Clinical trials
- Society and culture
- Legal status
- References
- External links
{{Drugbox | verifiedrevid = | drug_name = | INN = | type = | image = Tecovirimat.svg | image_class = skin-invert-image | width = 200 | alt = | caption =
| pronounce = | tradename = Tpoxx | Drugs.com = | MedlinePlus = | licence_CA = | licence_EU = | DailyMedID = Tecovirimat | licence_US = | pregnancy_AU = | pregnancy_AU_comment = | pregnancy_category= | routes_of_administration = By mouth, intravenous | class = | ATCvet = | ATC_prefix = J05 | ATC_suffix = AX24 | ATC_supplemental =